Thomas R. Cannell
2018 - Eleven Biotherapeutics
In 2018, Thomas R. Cannell earned a total compensation of $2M as President and Chief Executive Officer at Eleven Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $97,500 |
|---|---|
| Option Awards | $1,434,362 |
| Salary | $198,012 |
| Other | $280,000 |
| Total | $2,009,874 |
Cannell received $1.4M in option awards, accounting for 71% of the total pay in 2018.
Cannell also received $97.5K in non-equity incentive plan, $198K in salary and $280K in other compensation.
Rankings
In 2018, Thomas R. Cannell's compensation ranked 5,725th out of 14,244 executives tracked by ExecPay. In other words, Cannell earned more than 59.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,725 out of 14,244 | 60th |
Division Manufacturing | 2,166 out of 5,765 | 62nd |
Major group Chemicals And Allied Products | 804 out of 2,128 | 62nd |
Industry group Drugs | 671 out of 1,817 | 63rd |
Industry Pharmaceutical Preparations | 519 out of 1,391 | 63rd |
Source: SEC filing on April 30, 2019.
Cannell's colleagues
We found three more compensation records of executives who worked with Thomas R. Cannell at Eleven Biotherapeutics in 2018.
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019